Israel Englander Spring Works Therapeutics, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 503,868 shares of SWTX stock, worth $23.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

503,868

Previous 25,100 1907.44%

Holding current value

$23.2 Million

Previous $906,000 2354.19%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$32.5 - $59.93 $16.4 Million - $30.2 Million	503,868 New	503,868 $22.2 Million
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $1.95 Million - $2.6 Million	60,899 Added 413.88%	75,613 $2.42 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $24.9 Million - $32.9 Million	-690,825 Reduced 97.91%	14,714 $554,000
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $24.5 Million - $35.2 Million	671,334 Added 1962.68%	705,539 $34.7 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $647,842 - $1.27 Million	34,205 New	34,205 $1.25 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $334,822 - $456,576	13,409 Added 9.84%	149,655 $3.85 Million
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $746,447 - $986,560	-34,351 Reduced 20.14%	136,246 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $2.58 Million - $4.24 Million	106,925 Added 167.93%	170,597 $4.87 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $1.17 Million - $3.82 Million	63,672 New	63,672 $1.57 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $734,060 - $981,245	-14,990 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $1.64 Million - $2.33 Million	-30,767 Reduced 67.24%	14,990 $929,000
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $2.87 Million - $4.04 Million	45,757 New	45,757 $2.9 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $5.26 Million - $6.68 Million	-77,990 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $2.76 Million - $3.97 Million	-42,403 Reduced 35.22%	77,990 $5.74 Million
Q4 2020 Feb 16, 2021	SELL	$48.36 - $77.92 $1.88 Million - $3.02 Million	-38,812 Reduced 24.38%	120,393 $8.73 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $4.8 Million - $6.9 Million	-132,803 Reduced 45.48%	159,205 $7.59 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $5.31 Million - $11.2 Million	231,248 Added 380.59%	292,008 $12.3 Million
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $1.12 Million - $2.27 Million	55,037 Added 961.68%	60,760 $1.64 Million
Q4 2019 Feb 14, 2020	SELL	$17.74 - $39.52 $7.06 Million - $15.7 Million	-397,890 Reduced 98.58%	5,723 $220,000
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $7.59 Million - $11.2 Million	403,613 New	403,613 $8.75 Million

Others Institutions Holding SWTX

# of Institutions

361

Shares Held

63.1M

Call Options Held

5.81M

Put Options Held

2.55M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.88B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account